Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-Bevacizumab or FOLFIRI-bevacizumab: Results from ARIES, a bevacizumab observational cohort study

Johanna C. Bendell, Tanios S. Bekaii-Saab, Allen L. Cohn, Herbert I. Hurwitz, Mark Kozloff, Haluk Tezcan, Nancy Roach, Yong Mun, Susan Fish, E. Dawn Flick, Darshan Dalal, Axel Grothey

Research output: Contribution to journal › Article › peer-review